Closing the gap of older adult recruitment to cancer clinical trials: a scoping review Authors: Sarah Dillon, Rose Galvin, Deirdre Hartigan, Ruth Clifford, Niamh Peters, Katie Robinson, Margaret O’Connor, Patrick O’Donnell Published: 2026 ABSTRACT AbstractBackgroundAlthough they constitute a large proportion of those with cancer, older adults remain underrepresented in cancer clinical trials (CCTs). This scoping review aims to map the available literature regarding barriers and enablers to the recruitment of older adults to CCTs.MethodsA comprehensive literature search was conducted in CINAHL, PsycINFO, PubMed/MEDLINE, C2-SPECTR Campbell Systematic Reviews and Cochrane Library from 2004 to January 2026. Records were screened by two independent reviewers. Data related to study characteristics and findings were extracted in duplicate. Original research including older adult participants (having a median/mean age of 60 years or older) with any cancer diagnosis (haematological or solid tumour), which explored factors relating to their recruitment to CCTs were eligible for inclusion.ResultsA total of 29,160 records were identified through database searches. After screening, 30 studies met the inclusion criteria. Fifteen studies investigated patients, 3 investigated patients and carers, 4 investigated physicians/oncologists or providers, 2 investigated researchers and 6 had mixed populations. Studies were conducted in the USA (n = 19), Canada (n = 4), the Netherlands (n = 2), France (n = 3), Germany (n = 1) and Ireland (n = 1). Interpersonal, intrapersonal, environmental and institutional factors were the most commonly cited factors influencing CCT participation. Notably, the caregiver perspective was underexplored, despite caregivers often being framed as integrally important for making CCT decisions. Among the factors that could be modified were the physician/patient relationship, lack of information, and mistrust. Seven studies were identified that focused on interventions to increase recruitment, with varying approaches utilised.ConclusionIntrapersonal, interpersonal, institutional and environmental factors were among the most cited influences on CCT participation in older adults. The patient-physician relationship appeared to hold substantial influence, acting to both discourage or encourage participation, with institutional factors limiting clinicians’ ability to communicate about trials. Greater consideration of the opinions of carers is recommended, given their importance in supporting treatment. Identification of these factors can inform the development of future research and can provide actionable insights into how CCT teams may encourage participation of older adults. Institutional commitment will be needed to ensure equitable access to trials, with further studies examining recruitment strategies required to justify the resource-intensive nature of this effort.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12885-026-16051-w.Keywords: Health equity, Older adults, Cancer clinical trials, Recruitment, Ageing, Scoping review Background Cancer is among the leading causes of death worldwide [1] and it is projected that in 2026, over 2.1 million new cancer cases will occur in the United States [2]. This rise in cancer cases is coupled with a growing older adult population, with 1 in 6 people globally predicted to be aged 60 years or over by 2030 [3]. As a widely considered age-related disease [4, 5], the growing prevalence of cancer has the potential to overwhelm health systems. In the United States, for example, it is estimated that by 2030, around 70% of all new cancer cases will be in patients 65 years and older [6]. These trends necessitate ongoing innovation and the development of novel treatment strategies, with cancer clinical trials (CCT) imperative in advancing medical knowledge and patient care. Although CCTs serve as a key method of evaluating the safety and efficacy of a wide variety of management strategies, some populations have long been excluded. Older adults are among the most underrepresented groups in medical research [7], despite constituting a large proportion of those with cancer. Whilst interpretations of the term “underserved” vary, as a collective, older adults have many of the characteristics of “underserved groups” outlined by the National Institute for Health and Care Research [8]. These include lower-than-expected representation in research relative to their population size, despite their high healthcare burden. For example, although representing 43% of those with non-small cell cancer in the population, people over 75 constituted just 7% of participants in clinical trials for drugs and biologics approved for this condition [9]. Additionally, meaningful variations may exist in how older adults respond to, or engage with, CCTs compared to others, differences that are often overlooked or inadequately addressed in research [8]. This inequity in inclusion requires reconciling, not only in the interest of fairness, but also to ensure appropriate supports are in place for this expanding population. The issue of low levels of recruitment of older adults to CCTs is multifaceted and complex [8]. Firstly, it creates inequity in treatment pathways. CCTs often offer alternative solutions when traditional treatments have failed, or may provide innovative, and potentially superior management strategies. Therefore, the exclusion of older adults from these pathways hinders equitable access to care [10]. Secondly, clinical trials are important for ensuring appropriate application and safety of therapies to specific populations. The response of certain groups to interventions is reliant on a unique interaction of logistical, psychological, physical, cultural, and social factors. Therefore, if clinical trials do not include these underserved groups, data will be constrained and non-generalisable. Deriving evidence for treatment decisions based on younger demographics has been criticised as “informed guesswork” which can compromise safety [11]. Older adults have variable responses to treatments, such as pharmacotherapy [12, 13], meaning the extrapolation of data from younger populations may be inappropriate, potentially jeopardising health outcomes. Moreover, this paucity of evidence can diminish physicians’ confidence in prescribing novel medications or other interventions for those groups in the future, fearing these safety implications or unanticipated side-effects, which can further perpetuate inequity. Previous studies on CCTs have shed light on factors contributing to the underrepresentation of older adults. Notably, Ford et al. [14] and Sedrak et al. [15] highlighted several barriers to involvement in cancer research, using a systematic review methodology. Ford et al. [14] examined under representation of many marginalised groups, categorised barriers into four levels; patient level, provider level, study design level and health system level finding that access and opportunities were lacking for older adults, More recently, Sedrak and colleague’s [15] analysis of older adult participation found minimal intervention research, with only one study identified aimed at improving recruitment. Since these reviews were published, further research has emerged, and we now require further synthesis to identify the most contemporary and effective solutions to this issue. Moreover, previous studies have focused on barriers to CCT involvement, therefore we propose an exploration that includes identifying enablers to provide additional insights into targeted solutions to systemic underrepresentation. In light of these gaps, a scoping review methodology was chosen to assess the extent and type of literature relating to the recruitment of older adults to CCTs. Specifically, this study aimed to address the following research questions: What is the evidence relating to barriers and facilitators to the recruitment of older adults to CCTs? What is the evidence relating to barriers and facilitators to the recruitment of older adults to CCTs? What is the evidence relating to interventions aimed at improving recruitment of older adults to CCTs? What is the evidence relating to interventions aimed at improving recruitment of older adults to CCTs? Methods Study design and inclusion criteria This scoping review was conducted in line with guidelines from JBI [16] and following the PRISMA-ScR Checklist [17] (Related File 1) to ensure methodological transparency and rigour. The review protocol (CRD42024518076) was published a-priori and aimed to include all underserved individuals. This was later refined to focus on older adults. The original protocol proposed a rapid review; however, the high volume of articles and nature of the review question prompted us to adopt a scoping review methodology to comprehensively map all available literature. The Population, Concept, Context (PCC) framework was adopted, as outlined by JBI, to detail the inclusion criteria clearly [18]. The population consisted of older adults with a median/mean age of 60 years or older with cancer and their caregivers, and/or healthcare professionals working with this group. The concept involved examining the recruitment of older adults, and the context related to CCTs involving any intervention or setting. Clinical trials were defined as per the World Health Organisation definition as “any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes” [19]. To be eligible, studies must have been published in English and have had a focus on recruitment of older adults to CCTs mentioned within the abstract. If the identification of CCTs could not be determined by screening the abstract or title, the full text was examined for eligibility. Studies that solely reported participant characteristics without exploring the reasons for underrepresentation of older adults in CCT were excluded, as well as conference papers and narrative reviews. Peer-reviewed primary research articles and eligible primary research articles from the reference list of systematic or scoping reviews were extracted and included. A period of 20 years was chosen to ensure research was contemporary and reflective of existing barriers. Search strategy and source of evidence selection A comprehensive literature search was conducted in CINAHL, PsycINFO, PubMed/MEDLINE, C2-SPECTR Campbell Systematic Reviews and Cochrane Library between January 2004 to February 2024. The search strategy is available in Additional File 1. A repeat updated search was performed in January 2025 and January 2026. All references were imported into Rayyan, and duplicates were removed using Rayyan’s deduplication function, which removed duplicate articles with a 97% similarity rating or exact match of DOI.Any additional duplicates were manually resolved. Records were initially screened by title and abstract by two independent reviewers (SD & RG) using the above criteria for PCC. Full texts of potentially eligible articles were then retrieved and assessed independently (SD & RG). Discrepancies were resolved through discussion and consensus at regular meetings of four researchers (SD, POD, DH & RG). Data charting process and synthesis Custom data extraction forms were developed and piloted in Microsoft Excel. The first form detailed aspects of study design, including the methodology, country of study and participant demographics. A narrative analysis of barrier and facilitator findings was conducted, broadly using the Social Ecological Model described by Wells and Zebrack [20], which describes six psychosocial factors influencing participation in CCTs. This model was chosen for its ability to categorise the factors influencing participation in a nuanced manner. Within this model, intrapersonal refers to within-person factors (e.g., beliefs), and interpersonal relates to between-person influences (e.g., relationships). Environmental factors encompass aspects such as accessibility, whilst community relates to leadership and public–medical partnerships. Socio-cultural factors include cultural norms (e.g. medical mistrust), and finally, institutional factors relate to resources and funding. An additional category, “patient characteristics”, was created to encompass non-psychosocial aspects of patient status. Barriers and enablers to participation were extracted in duplicate and cross-checked. Discrepancies were resolved through discussion. Data from interventions to increase recruitment-based studies were similarly charted. Public and patient involvement The concept for this evidence synthesis was shaped by a Public and Patient Involvement (PPI) stakeholder panel consisting of a heterogeneous group of older adults and caregivers. In May 2025, circa 20 PPI panel members discussed older adults’ participation in clinical trials via a facilitated discussion by co-authors KR and RG. The panel was provided with a verbal and visual (PowerPoint) lay summary of results and the interpretation from a draft manuscript and were asked to discuss and provide feedback on their thoughts. This led to broad agreement on the researchers’ interpretations and findings, which resonated with the experiences of the group regarding their hypothetical and lived experiences of engaging in clinical trials. The panel highlighted peer (family, friend, carer) influence as key in decisions about trial participation and authors have made efforts to reflect this in the results/discussion. Results Study selection A total of 29,160 records were identified through database searches. After screening, 30 studies met the inclusion criteria. The PRISMA flow diagram (Fig. 1) provides an overview of the study selection process. PRISMA flow diagram Study characteristics Table 1 describes the characteristics of included studies. Of the 30 studies, 15 investigated patients, 3 investigated patients and carers, 4 investigated physicians/oncologists or providers, 2 investigated researchers, and 6 had mixed populations. All studies investigated recruitment, with one additionally exploring retention [21]. Studies were conducted in the United States of America (n = 19), Canada (n = 4), the Netherlands (n = 2), France (n = 3), Germany (n = 1) and Ireland (n = 1). Varying designs were employed to explore enablers and barriers to CCTs, including quantitative (n = 14), qualitative (n = 8), and mixed-methods (n = 3) approaches (Additional File 2). Seven studies included initiatives to increase recruitment to CCTs, two of which were randomised trials. Table 1Details of studiesAuthorMethodologyMethodAim of studyPopulation examined (type of cancer studied)Description of populationMoore et al. (2004) [22]QuantitativeProvider-recorded surveyTo examine how often peoplewith ovarian cancer are enrolled into CCTs and examine factors affecting enrolment.Older adults with cancer (ovarian)n = 287, all female, age ≥ 65.Kimmick et al. (2005) [23]Intervention StudyRandomised controlled trialTo compare the effects of a multifaceted educational intervention versus standard information on accrual of older persons to cancer treatment trials.Physicians (mixed types/locations)n = 6431 patients, gender NR, age ≥ 65.Townsley et al. (2006) [24]Mixed methodsSelf-administered survey and semi structured interviewTo explore attitudes of the older adults about participation in clinical trials to determine if this is one of the barriers to the involvement of this population in clinical trials.Older adults with cancer (mixed types/locations)Survey: n = 94, 54% male, 45% female, 1% NR, 80% aged 70–79. Interviews: n = 17, 47% female, 53% male, 65% aged 70–74.Basche et al. (2008) [25]QuantitativeInvestigator administrated surveyTo describe patient/family and logistical barriers to participation in university-based, early-phase CCTs for adults age ≥ 65 years, and to identify influences on their decisions to participate.Older adults with cancer (advanced cancer)n = 300, 51.5% male, 48.5% female, 51% aged 65–74, 49% aged ≥ 75.Puts et al. (2009) [21]QualitativeInterviewsTo examine strategies to recruit older newly diagnosed cancer patients prior to treatment into an observational prospective pilot study and to evaluate retention during a six-month period.Older adults with cancer (mixed types/locations)n = 152 (112 participated: 70% male, 30% female, mean age 73.7 ± 6.0); 40 refused (53% male, 47% female, mean age 74.4 ± 5.8).Javid et al. (2012) [26]QuantitativeSurveyTo compare patient- and physician-perceived barriers to enrolment to CCTs by age group (over 65 vs. under 65).Older adults with cancer, physicians (breast cancer)Patients: n = 58, all female, age ≥ 65.Hempenius et al. (2013) [27]Quantitative and Intervention StudyIntervention and unclearTo evaluate CCT non-invitation and refusal rates. To identify factors associated with non-invitation and refusal. To assess experiences of CCT participation from the patients’ and professionals’ perspectives.Older adults with cancer, clinical research professionals (mixed types/locations)Clinical professionals : n = 11, 91% female, 9% male. Quantitative: n = 265, 184 women, 81 men, median age 76 [IQR 72–81]). Interviews: n = 25 (20 accepted CCT, 5 refused), gender NR, age ≥ 65.Hamaker et al. (2013) [28]QuantitativeSurveyTo explore potential barriers in the accrual process to the OMEGA study.Coordinating investigator (breast cancer)Patients: n = 78, gender NR, median age 75.5 (range 65.8–86.8). Investigators: n = 15, gender and age NR.Mancini et al. (2014) [29]QuantitativeSurveyTo compare the desire for research involvement of older (≥ 65) and younger individuals with cancer.Older adults with cancer (mixed types/locations)Total: n = 574 (33.1% ≥65), age breakdown: 65–74 (21.4%), 75–84 (10.3%), ≥ 85 (1.4%), 22% female, 88% male.Krieger et al. (2014) [30]QualitativeSemi-structured interviews and focus groupsTo examine how medically underserved women conceptualize clinical trials by exploring the language they use to describe them. To examine how participants interpret metaphors used to explain randomisation in CCTs.Low-income older adult women with cancer, women caregivers (mixed types/locations)Interviews: n = 11, all female, mean age 68.45 ± 12.3.Focus group: n = 30, all female, mean age 67.2 ± 9.65.Ayodele et al. (2016) [31]QuantitativeSelf-administered surveyTo determine the attitudes of patients towards CCTs and assess the differences between older and younger patients.Older adults with cancer (mixed types/locations)n = 100, 43% male, 57% female, median age 69 (range 55–81).McCleary et al. (2018) [32]Mixed methodsTown hall meeting (patient advocates, community oncologists and academic centre leaders) and survey (Primary Investigator)To investigate challenges faced and reasons for poor accrual to a CCT.Patient advocates, community oncologists and academic centre leaders, principal investigators (colorectal cancer)n = 24 principal investigators, gender and age NR.Freedman et al. (2018) [33]QuantitativeSurveyTo examine awareness of current accrual patterns for older patients to CCT, to ascertain consensus on how to tackle enrolment challenges, and to provide the impetus for high-level changes to improve CCT accrual of older patients.Alliance for Clinical Trials in Oncology members including a national diverse sample of physicians, nurses, administrative/clinical research staff, and patient advocates with representation from community, academic, and rural sites. (mixed types/locations)n = 1146 (67.4% female), 29.7% ≤40, 23.4% ≥61.Prieske et al. (2018) [34]QuantitativeSurveyTo explore the disposition and apprehension of older adults with gynaecological cancers toward study participation.Older adults with cancer (gynaecological cancer)n = 112, all female, median age 70 (range 65–92).Sedrak et al. (2020) [35]QualitativeSemi-structured interviewsTo explore oncologists’ perceptions of barriers to clinical trial enrolment of older adults with cancer.Oncologists (mixed types/locations)n = 44, 64% male, 36% female, age NR.Lackman et al. (2020) [36]QuantitativeChart review and cross-sectional surveyTo determine physician-stated reasons for non-accrual of older patients, age 65 and over, to clinical studies.Medical oncologists (mixed types/locations)n = 252, 51% female, 49% male, median age 66 years (range 19–94).Owusu et al. (2021) [37]Intervention StudyComparative studyTo examine recruitment strategies in older breast cancer survivors who participated in an exercise intervention study.Older adults with cancer (mixed types/locations)n = 213., all female, median age 70 (range 65–88).Hagège et al. (2021) [38]QualitativeSemi structured interviewsTo investigate the collaboration between geriatricians and oncologists in the inclusion process of older patients in CCTs.Geriatricians and oncologists (mixed types/locations)n = 16, 50% female, 50% male, age NR.Tsang et al. (2022) [39]QualitativeSemi-structured interviewsTo explore older adults’ experiences and deliberations with phase 1 trials.Older adults with cancer +/- caregivers assisting (advanced, mixed types/locations)n = 39, 38% female, 62% male, 56% aged 65–70, 44% >70.Hopkins et al. (2022) [40]QuantitativeSurveyTo explore barriers and facilitators to recruitment of older adults to CCTs.Clinicians and staff within the National Community Oncology Research Program (mixed types/locations)n = 305 (50% coordinators, 38% physicians, 5% admins, 3% APPs, 5% other).BrintzenhofeSzoc et al. (2022) [41]QualitativeFocus groupsTo explore the needs and concerns of older adults with cancer regarding clinical trials.Older adults with cancer (mixed types/locations)n = 8, 88% female, 12% male, mean age 75 ± 4.7 (range 67–81).Warnock et al. (2022) [42]Intervention StudyNested study within RCTTo compare response rates to business letter versus greeting card invitations used to recruit older cancer survivors to a randomised controlled CCT of a lifestyle intervention.Older adults with cancer (mixed types/locations)n = 708, 59% female, 41% male, mean age 72.Sedrak et al. (2022) [43]QuantitativeScreening logsTo compare enrolment patterns, ineligibility, and reasons for decline among older and younger adult cancer patients in community settingsData obtained by research staff, provided by older adults with cancer (mixed types/locations)n = 2298, 1709 < 70: 80% female, 20% male, mean age 60 ± 5.7; 589 ≥ 70: 64% female, 36% male, mean age 74.7 ± 4.4.Barnes et al. (2023) [44]QualitativeInterviewsTo explore the barriers and facilitators to participating in exercise prehabilitation from the perspective of older people with frailty participating in the intervention arm of a randomised trial.Older adults with cancer (intraabdominal and intrathoracic cancers)n = 15, 53% female, 47% male, average age 72.Mokhnatkin et al. (2023) [45]QualitativeSemi-structured interviewsTo explore the aligned and misaligned perspectives around clinical trial enrolment among patient-caregiver dyads.Older women and their caregivers (breast cancer)n = 32 (16 dyads), 81% female, median patient age 70–79.Hagège et al. (2024) [46]Mixed MethodsSemi-structured interviews and sociodemographic and health dataTo evaluate CCT non-invitation and refusal rates.Older adults with cancer and clinical research professionals (mixed types/locations)Qualitative: 11 clinical research professionals, 91% female, 9% male. Quantitative: n = 265, 69% female, 31% male, median age 76 (IQR 72–81).Friedman et al. (2024) [47]QuantitativeProvider recorded decisions.To examine geographic factors impeding CCT enrolment. To improve access to CCTs for Veterans.Provider recorded (blood cancer)n = 33, all male., mean age = 71 range 41–92.Arana-Chicas et al. (2025) [48]QualitativeSemi-structured InterviewsTo explore the barriers impacting the participation of rural older adult survivors in CCTs.Rural older adult survivors of cancer (mixed types/locations)n = 27, 59% female, 41% male, mean age 73.4 ± 5.0.Sitemba et al. (2025) [49]Intervention StudyComparative StudyTo examine the recruitment across various strategies, and to describe retention and adherence to the trial.Postmenopausal cancer survivors (mixed types/locations)n = 442, all female, mean age = 62.0 ± 6.4 (completers), 62.3 ± 5.8 (non-completers).Friedman et al. (2026) [50]Intervention StudyDescriptive studyTo describe the development and examples of decentralized CCT.Veterans with cancer (reporting by investigators)n = 134 in decentralized CCTs, 10% female, 90% male, median age (IQR) = 71(65–76).Abbreviations: CCT Cancer clinical trial, RCT randomised controlled trial, NR not reported Details of studies To examine how often people with ovarian cancer are enrolled into CCTs and examine factors affecting enrolment. Interviews: n = 11, all female, mean age 68.45 ± 12.3. Focus group: n = 30, all female, mean age 67.2 ± 9.65. Abbreviations: CCT Cancer clinical trial, RCT randomised controlled trial, NR not reported Synthesis of results Intrapersonal Intrapersonal factors were commonly cited influences on trial participation. In some cases, this was simply stated as “patient refusal” or “patient not interested”. However, many studies indicated patient concerns as a barrier to participant, often related to the clinical trial itself, particularly mistrust of clinical trial practices. Concerns relating to questionable effectiveness and side effects were prominent [24, 26, 31, 34, 43, 45, 48]. The experimental nature of the trials was viewed in a negative light [35]. Aspects of the trial, such as randomisation and fairness, were worrisome for participants [28, 30, 41, 48]. Patients also expressed unease about the overwhelming nature of the process, either in dealing with the diagnosis or finding appropriate clinical trials [21, 36, 39, 51]. Participants noted that misinformation and/or a lack of information around clinical trials was a deterrent for them [24, 29, 33, 34, 45, 48]. The belief that they would not benefit personally or even make a societal benefit was cited as a barrier to some [26], though in other studies, personal and societal benefit was seen as an enabler to participation [24, 26, 31, 34, 39, 41, 45, 48]. The perceived personal benefit in terms of improved care, closer monitoring, better health outcomes, fewer symptoms, and increased lifespan was noted as a facilitator to participation in many instances [24, 25, 31, 34, 41, 44, 45, 48]. Interpersonal Several factors were identified that pertain to interpersonal influences on CCT participation, with many studies identifying the pivotal role of the family doctor, oncologist, or medical team. Physician judgment and communication were seen as important influential factors, acting both as an enabler [24–26, 29, 31, 34, 39, 41, 45, 48] and barrier [24, 26, 28–32, 35, 38–41, 45] to participation in CCTs. Similarly, caregivers and friends also exerted influence on decision-making, in both enabling [24–26, 40, 41, 44, 45, 51] and discouraging [25, 26, 33, 35, 40, 43, 51] participation. Social isolation was also cited to be related to non-participation [46]. Investigator decision was also a factor in not enrolling patients, even if they were technically eligible and a trial was available [22]. Environmental Environmental factors largely acted as barriers to participation. Among the reasons for non-participation were logistical issues, such as transport or distance from the centre [25–27, 31, 33–36, 40, 43, 45, 47, 48]. The time required to participate was identified as a barrier to participation in CCTs [21, 25, 26, 33, 34, 40, 43, 45], whilst concern about the financial implications of participation also dissuaded participation [21, 26, 41, 43]. Enablers included directly addressing these challenges by providing transport vouchers [40] and patient-reported comfort with trial financial arrangements [26]. Community No studies cited community factors to be related to participation in CCTs. Sociocultural Lower education/literacy levels [29, 36, 46] and language barriers [36] dissuaded participation in CCTs. Some trials pointed to ageist beliefs of clinicians or research cultures that did not consider older adults [35, 38, 40, 41], impeding participation. Whilst also reflected under intrapersonal factors, mistrust of CCTs and fears of being treated like guinea pigs/animals appeared in multiple studies [25, 30, 34, 35, 41, 48] and may be reflective of the societal attitudes of this group towards CCTs. One study suggested that the use of culturally appropriate metaphors for explaining randomisation or equal chance enabled participation [30]. Institutional Institutional factors were prevalent, acting both as a barrier and an enabler to undertaking CCTs. Many studies cited that the lack of availability of suitable CCTs within the institution was a barrier to participation [26, 33, 35, 36, 40, 41]. Several studies indicated that limited staff awareness of clinical trials led to missed referral opportunities [24, 27, 41], while others found that patients were not adequately informed about available clinical trials [26, 35, 45, 48]. Limited institutional support, such as insufficient dedicated staffing and time allocation, constrained enrolment efforts, particularly given the burdensome nature of enrolment and pretesting processes [28, 29, 33, 35, 38, 40, 45]. Enablers suggested to address these challenges included enrolment targets for older adults [33], simplifying recruitment materials [26, 40] and less time-consuming screening processes [38]. Patient navigators were discussed in some studies for their potential to improve recruitment [40, 41, 45]. This role, typically undertaken by nurses or other healthcare professionals, involves personal guidance of patients through the care process. Patient-related Patient-related factors mostly pertained to barriers to participation in CCTs, with key considerations including poor performance status, frailty, and the potential risk of treatment-related toxicities [21, 24–26, 28, 29, 31–33, 35, 36, 40, 41, 44, 46, 47]. Interventions to improve accrual Several interventions were proposed to improve CCT recruitment (Table 2). Some studies examined the effect of a single strategy on recruitment. Warnock et al. [42] found that standard business letters sent to prospective older adult participants were more effective than greeting cards for recruitment to a lifestyle RCT. Owusu et al. [37] also targeted initial recruitment, finding that direct referrals yielded the highest recruitment rates with respect to enrolling older adults when compared to using hospital or state registries. Similarly, Sitemba et al. [49] compared recruitment channels for an exercise trial, finding comparable effectiveness between recruiting via cancer registries, clinician referral, community outreach, or mailed invitations previous research participants. However, screening and recruiting via health records accrued zero participants. At a broader multisite level approach, one study [50] examined the impact of decentralized trials on the recruitment of veterans with cancer, suggesting that this strategy may improve trial access for rural-dwelling older adults in this population compared to traditional CCTs. Multicomponent strategies, involving the implementation of several intervention components were implemented in five studies [21, 23, 27, 49]. Of these, two [23, 27] compared recruitment rates between control and intervention groups or between pre- and post-intervention time points. One study [51] reported increases in recruitment compared to pre-intervention using a combination of strategies including advertisement of the study via branded merchandise, screening of patient lists to ensure reach, employment of a nurse navigator and involvement of caregivers in enrolment, emphasising the importance of the nurse navigator in this success. Contrastingly, an educational intervention to improve at physicians knowledge and awareness of CCTs, as well inserting trial information in charts and providing trial reminders did not lead to increased accrual compared to usual information [23]. Puts et al. [21] also implemented a multicomponent strategy, which included identification of eligible patients from appointment lists, using physicians as gatekeeps for patient contact and through adding recruitment letters to patient charts. Though not compared to any other strategies or previous accrual rates, a recruitment rate of 72% was yielded. Finally, just two studies explored retention to CCTs [21, 49]. Sitemba et al. [49] implemented multicomponent strategies such as free parking, trial merchandise and the fostering of peer support. Puts and colleagues [21] reported retention efforts that included home visits, flexible scheduling, transportation support and compensation, ensuring on consistency in research staff, appointment reminder letters and diverse literacy formats for data collection. These strategies culminated in retention rates of 87% and 81% respectively, though this no comparison to a control condition was done. Table 2Initiatives to enhance recruitment to cancer clinical trialsStudyInitiativeComparisonOutcomeKimmick et al. 2005 [23]Educational intervention which included standard information plus: (1) an educational symposium; (2) geriatric oncology educational materials; (3) monthly mailings and emails for 1 year; (4) lists of available protocols for use on patient charts; and (5) a case discussion seminar.Standard information.The intervention did not improve accrual of older adults to CCTs.There was no improvement in accrual in the intervention versus control arm: 36% v 32% in the first year and 31% v 31% in the second year.Warnock et al. 2022 [42]Business letter for recruitmentGreeting card for recruitment.A business letter yielded higher positive response rates to CCT recruitment (73% increase) as compared to greeting card formatted invitations.Owusu et al. 2021 [37]Direct referral of older adults to CCTs.Referral of older adults to CCTs through hospital and state registries.Recruitment rates were higher using direct provider and community partner referrals (84%) versus state (2%) or hospital-based registries (8%).Hempenius et al. 2013 [27]Increase general awareness of the study, posters, pencils and sweet jars with the logo of the study were distributed to the outpatient clinics and wards. Checking of patient lists to detect unscreened patients. Involvement of relatives in informed consent process. Employment of nurse with experience of patient population.Previous enrolment before the initiative.Recruitment intervention significantly increased number of patients enrolled.Puts et al. 2009 [21]Recruitment Strategy:Identified eligible patients from appointment lists at oncology-related clinics.Added a letter (with inclusion/exclusion criteria and patient info) to the chart of each eligible patient.Treating physician asked eligible patients for permission to be contacted by the research team.Research team then followed up by phone or in person post-consultationRetention Strategy:Offered home visits and flexible scheduling to accommodate participant preferences.Provided transportation support and compensation.Allowed splitting of study participation over multiple sessions.Ensured interviews were conducted by the same staff member when possible.Sent holiday cards to maintain engagement.Issued fridge magnets with contact information for easy study team access.Sent reminder letters before each telephone interview, including the questionnaire to facilitate the process.Offered alternative formats for visually/hearing-impaired participants (e.g., face-to-face interviews or mailed questionnaires).Obtained permission to contact a proxy if participants became unreachable or unwell during follow-up.No comparison.Recruitment and retention intervention resulted in participation of 72% of eligible patients in CCT, 81% were retained at the six-month follow up.Sitemba et al. (2025) [49]Recruitment Strategy:Cancer registries, clinician referral, mailed invitations to past research participants, community outreach (recruitment flyers across community, advertising in social and print media, engagement in community organisations), screening and outreach through electronic health record.Retention Strategy:Assigned all participants (including controls) to a group exercise programme.Provided free parking a short distance from the classes/study site.Provided a $10 gift card following completion of each testing session.Provided trial tokens, such as a magnet and a t-shirt.Sent birthday cards to participants.Adherence Strategy:Provision of expert coaching to provide input during the exercise programme.Provided a week-long exercise induction to educate participants and establish rapport.Frequent communication between instructors and participants about absences from classes and tolerance to exercises.Developed group dynamics in exercise classes to encourage peer support.Celebrated mid and end point of exercise programme.Comparison of recruitment strategies.No comparison of retention and adherence strategies.The accrual rate of interested personswas similar across all initial strategies, ranging from 29 to37%, except for EHR screening which resulted in zero accruals.The recruitment rate of participants was similar across all strategies (29–37%), apart from screening and outreach through the electronic health record, which yielded no referrals. Of the participants recruited, 87% were retained within the trial.Friedman et al. (2026) [50]Recruitment Strategy: Decentralization of CCTs.Comparison to other literature.Decentralized clinical trials contained higher percentage of rural veteran patients than typical CCTs.Abbreviations: CCT Cancer clinical trials Initiatives to enhance recruitment to cancer clinical trials The intervention did not improve accrual of older adults to CCTs. There was no improvement in accrual in the intervention versus control arm: 36% v 32% in the first year and 31% v 31% in the second year. Recruitment Strategy: Identified eligible patients from appointment lists at oncology-related clinics. Added a letter (with inclusion/exclusion criteria and patient info) to the chart of each eligible patient. Treating physician asked eligible patients for permission to be contacted by the research team. Research team then followed up by phone or in person post-consultation Retention Strategy: Offered home visits and flexible scheduling to accommodate participant preferences. Provided transportation support and compensation. Allowed splitting of study participation over multiple sessions. Ensured interviews were conducted by the same staff member when possible. Sent holiday cards to maintain engagement. Issued fridge magnets with contact information for easy study team access. Sent reminder letters before each telephone interview, including the questionnaire to facilitate the process. Offered alternative formats for visually/hearing-impaired participants (e.g., face-to-face interviews or mailed questionnaires). Obtained permission to contact a proxy if participants became unreachable or unwell during follow-up. Recruitment Strategy: Cancer registries, clinician referral, mailed invitations to past research participants, community outreach (recruitment flyers across community, advertising in social and print media, engagement in community organisations), screening and outreach through electronic health record. Retention Strategy: Assigned all participants (including controls) to a group exercise programme. Provided free parking a short distance from the classes/study site. Provided a $10 gift card following completion of each testing session. Provided trial tokens, such as a magnet and a t-shirt. Sent birthday cards to participants. Adherence Strategy: Provision of expert coaching to provide input during the exercise programme. Provided a week-long exercise induction to educate participants and establish rapport. Frequent communication between instructors and participants about absences from classes and tolerance to exercises. Developed group dynamics in exercise classes to encourage peer support. Celebrated mid and end point of exercise programme. Comparison of recruitment strategies. No comparison of retention and adherence strategies. The accrual rate of interested persons was similar across all initial strategies, ranging from 29 to 37%, except for EHR screening which resulted in zero accruals. The recruitment rate of participants was similar across all strategies (29–37%), apart from screening and outreach through the electronic health record, which yielded no referrals. Of the participants recruited, 87% were retained within the trial. Abbreviations: CCT Cancer clinical trials Discussion This scoping review aimed to explore the barriers and enablers to the recruitment of older adults to CCTs, identifying a range of contributing factors. This is an area of growing interest, with a sharp increase (n = 16) in the number of papers since the last review of literature in 2021 [15]. Additionally, this study expands on identifying six additional intervention studies, given just one was found in the previous review. An array of enabling and dissuading factors were identified, with interpersonal and intrapersonal factors being the most cited influences on participation. In many healthcare contexts, physicians are the gatekeepers of knowledge, with some patients signalling that clear information from these key actors supported their participation in CCTs [26, 41]. In contrast, patient non-participation was often attributed to being provided with limited or unclear information. Some studies suggested that this could stem from clinicians having insufficient knowledge of specific trials themselves [45, 51], and missed opportunities for referral [38, 41, 48]. In other cases, participation was hindered by a lack of time or resources to prioritise enrolment [33, 35, 40], reflecting institutional barriers. This appetite for clinical trial information from older adults reflects a desire for shared decision-making, characterised by reciprocal sharing of information as well as preferences for treatment between clinicians and patients [52]. This approach is increasingly recommended in contemporary guidelines [53], purported to be related to increased patient satisfaction [54] and at its core relies on effective communication and an equal relationship between clinicians and patients/carers [55]. Whilst the instinctive solution would be to improve education of clinicians and patients, an RCT by Kimmick and colleagues [23] found an educational intervention for clinicians alone to be unsuccessful compared to the standard approach. This outcome may be attributable to the persistence of institutional barriers not addressed by the educational intervention, such as insufficient support in terms of time and resources allocated to clinicians [28, 29, 33, 35, 38, 40, 45]. Moreover, research has indicated that changes to healthcare practices are more effective when individualised feedback is provided to clinicians about their performance, benchmarking them alongside their peers, preferably by a CCT champion who is known to the recipient [56]. This may be applied to future CCTs by encouraging clinician feedback on individual referral metrics, with oversight from a dedicated coordinator. Whilst lack of information was a key factor influencing participation in CCTs, misinformation and mistrust were also prominent barriers. Mistrust of medical professionals is widely accepted as an impediment to quality care, particularly among underserved communities such as African Americans, interlinked with a history of abuse and ill-treatment [57]. These findings are somewhat at odds with other literature, with some studies reporting higher trust among older adults compared to younger populations [58] and an overall trust in science [59]. Findings from our review suggest that mistrust /distrust includes factors concerned with the conduct of trials, with participants citing fears of being experimented on, fears of developing side effects, and misunderstanding randomisation. Although most studies indicated that patients tended to trust the opinions of their own physicians, this trust did not appear to extend to the wider medical community, who may not have been personally known to the patients. Greater interpersonal compared to institutional trust has been noted elsewhere [60], meaning that patients tend to trust specific clinicians, but may be wary of the system they operate within. It has been suggested that developing institutional trust must be approached through the proactive strengthening of partnerships with communities [61], and through identifying and directly targeting sources of mistrust. Fundamental to this is an institutional commitment shown by the allocation of appropriate resources and the establishment of clear accountability. Public and patient involvement (PPI) initiatives may be one way to facilitate trust and acceptance of CCTs and similar research projects [62], with a potential role of community partners in identifying research priorities, designing studies, and disseminating findings, with the aim of improving the relevance of research to communities. Whilst research has indicated that PPI is mostly integrated into research design and delivery, evidence of broader involvement of the public, such as advisory council membership or contributing to policy development, is weaker [62]. Enhanced visibility of PPI processes and their impact on health services may give the public greater confidence that researcher-public partnerships are established and meaningful. Interestingly, community-level factors were not identified as influencing recruitment in any of the studies reviewed. This could be attributed to the design of the studies, particularly the framing of questions in interviews or surveys that did not consider these factors. Given the potential for community engagement initiatives to successfully increase interest in CCTs among other populations [63], this is an evidence gap that should be explored in relation to older adults. Physicians hold an influential position in relation to CCTs, both acting as the conduit for trial information and holding power in advising on participation. Among older adults, physician opinion is both valued and, at times, directive. In some instances, patient preference was to defer to the physician to make care or participation decisions on their behalf [39]. Other studies suggested that physician bias hinders the consideration of older adults and may direct clinical trial options [40, 41]. Whilst physician decision not to refer patients for CCTs may be well-intended and borne out of concern for potentially vulnerable patients [40], paternalism in decision making has been previously criticised for eroding autonomy and disempowering patients [52, 64]. The issue of ageism in older adult care is echoed in the wider cancer care literature, with strategies to target conscious and unconscious biases and ageist assumptions yet to be evaluated [65]. Just three studies specifically investigated the opinions of caregivers or family members, despite evidence suggesting that they often play a substantial interpersonal role in influencing participation [25, 26, 33, 35, 40, 43, 51], and existing laws that recognise their role in decision-making in some jurisdictions [66]. Caregivers are often fundamental in supporting access to healthcare, with previous research finding that almost half the population of the United States aged 65 years and older receiving assistance with health or functional needs [67]. Therefore, understanding the views of caregivers is vital in order to address low levels of older adult participation in CCTs. Caregivers often play a critical role in aiding with barriers of transport to appointments, daily management of side effects, yet they are frequently overlooked in trial design, implementation, and evaluation. As such, the involvement of carers in shared decision-making when outlining CCT possibilities should be considered [55, 68]. Remedying the situation: the path forward for CCTs A number of interventions aiming to improve recruitment were described within this scoping review; however, wide variation in design, and inconsistent use of comparators limits the ability to make strong recommendations. Of the available, yet limited research, several potential solutions were identified as effective. Among these successful strategies were direct referrals rather than registries, as well as the issuing of business letters rather than greeting card information. Multimodal strategies that address multiple factors, such as increasing awareness, checking of patient lists and using patient navigators, also offered solutions to improve recruitment. These multi-pronged strategies may be effective given that age often intersects with other factors, affecting CCT participation, for example rurality, ethnic minority status, and socioeconomical disadvantage. Considering the intersectionality of underrepresented older adults and the complex interaction of psychosocial and physical factors associated with non-participation in CCTs, this is a nuanced issue, necessitating nuanced solutions. Patient navigation, a patient-centred approach to guide individuals with serious illness through the often complex and fragmented healthcare systems, may present a possible solution. Navigators, equipped with information about current and relevant CCTs, could assist patients in overcoming barriers such as understanding treatment options, logistical challenges, and navigating complex enrolment pathways. Moreover, as a dedicated point of contact, they can remind physicians about ongoing trials and ease the burden of recruitment by offering clear referral pathways. Whilst this approach was only implemented in one study included within our review, the researchers did find marked increases in CCT enrolment and retention after employing a nurse navigator [27]. Cancer care navigation, has been deemed valuable for other underserved populations, helping to reduce disparities in access to care and clinical trial participation [69]. Many of the above strategies target factors that limit participation of not just older adults, but also other underserved populations [70], meaning that implementing these interventions may enhance diversity at a wider level. Implications for practice and research This scoping review identified several implications for research and practice. Firstly, future research could assess the effectiveness of interventions for recruitment to CCTs, utilising pre- and post-intervention comparisons, RCT designs, or, perhaps, more feasibly, embedding evaluations of recruitment interventions within trials themselves via a Study Within Trials (SWAT) design. This level of evaluation is essential to justify the investment of resources, for example, employing patient navigators. Secondly, given the significance of caregivers in decision-making, their role must be considered when examining enrolment or non-enrolment. Notably, it is important that any integration of caregivers is done whilst respecting medico-legal aspects of confidentiality, highlighted within medical regulations [71]. Thirdly, it is striking that although all studies examined recruitment, just two studies explored retention beyond the point of enrolment [21, 49]. Both studies reported high retention rates (81% and 87% respectively) through the use of multimodal and practical strategies including free parking [49], flexible scheduling [21], monetary incentives [49], and transport support [21]. Future studies should similarly monitor retention to determine whether existing barriers to participation persist, or whether participant needs change over time. From a practical standpoint, strong institutional commitments will be necessary to effectively leverage facilitators and address barriers to participation. This includes the potential allocation of dedicated patient navigators to support informed consent processes for both patients and their caregivers, given the varied and personalised barriers associated with CCTs. Finally, whilst not a major focus of the present scoping review, it should also be noted that eligibility criteria often influence the inclusion of older adults in reviews [72], and whilst there is reason to believe this is improving [73], researchers themselves must consider equity when designing trials. It is important to note that in the absence of inclusive eligibility criteria, addressing the remaining factors will be fruitless, so this should be prioritised as a fundamental step towards older adult representation in CCTs. Justification of narrow eligibility criteria could be considered a requirement by funding or ethical approval bodies, with enhanced governance to mandate inclusion, similar to what is detailed in the Consolidated Appropriations Act 2023 [74, 75]. It should be noted when considering future actions and interpretation of this review’s findings, that the majority of studies were conducted in the United States. The distinct characteristics of this healthcare system, including affordability of care [76], and the cultural beliefs and values, likely influence the barriers and facilitators to participation in CCTs. Therefore, conclusions should be interpreted with caution as they may not be applicable to other contexts. Strengths and limitations This scoping review offers several notable strengths. It presents a comprehensive and systematic examination of the literature related to CCTs, providing a detailed categorisation of both psychosocial and physical barriers and facilitators to participation. However, a number of limitations exist. Firstly, this study only reports what barriers and facilitators were identified as being associated to CCTs and does not explore the extent of agreement about their importance. Furthermore, while some studies employed open-ended approaches which allowed participant-driven insights to emerge, some utilised more constrained formats such as structured surveys. These methodological restrictions may have limited the scope of responses and precluded a thorough exploration of barriers and facilitators across all relevant domains (e.g. community), potentially impacting the findings. Secondly, although the included studies focused on older adults and barriers and facilitators related to their representation in CCTS, in the absence of a comparison with barriers affecting younger populations, it is unclear if identified factors may also apply to younger participants. Thirdly, the heterogeneity of study designs, outcome measures and populations in the included studies limits strong conclusions. Finally, the studies identified were largely conducted in the United States and therefore conclusions may not be generalisable to other health systems. Conclusion This scoping review highlights the complex factors influencing the participation and non-participation of older adults in CCTs. A central finding is the pivotal role of the physician, both as a key influencer in treatment endorsement and as a central conduit of information. Whilst caregivers appear to play an essential role in clinical trial participation, their perspectives were seldom examined independently. Various interventions were identified to enhance the inclusion of older adults in CCTs. However, their heterogeneity and frequent lack of control groups limit the ability to draw definitive conclusions about their effectiveness. The use of patient navigation may be a promising strategy to address the multifaceted barriers and facilitators related to recruitment and retention in this population. Supplementary Information Additional file 1. Additional file 2. Acknowledgements The authors would like to acknowledge the contributions of the Ageing Research Centre Public and Patient Involvement Group to this paper. Abbreviations Cancer clinical trials Patient and public involvement Authors’ contributions All of the authors have contributed to the manuscript significantly and meet authorship requirements outlined by ICMJE. Conception and design: SD, RG, DH, RC, NP, KR, MOC, POD. Data acquisition and analysis: SD, RG, DH, POD, KR. Interpretation of Data: SD, RG, DH, POD, KR. Initial drafting: POD, SD, RG, DH. Review and approval of finalised draft: SD, RG, DH, RC, NP, KR, MOC, POD. All authors agree to be accountable for all aspects of the work. Funding This work is supported by an unrestricted grant from the Health Research Board of Ireland, Cancer Trials Enhancement Award (CTEA-2023-002). The funders had no role in developing the content of this manuscript. Data availability All data generated or analysed during this study are included in this published article. Declarations Ethics approval and consent to participate This work is a scoping review based on secondary data analysis; therefore, no research ethics approval was required. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Additional file 1. Additional file 2. Data Availability Statement All data generated or analysed during this study are included in this published article.